🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate the efficacy and safety of a fixed ...
Status
Completed
Location
Sites in USA
Start Date
2008-07
Trial ID
NCT00739596
Treatments Being Tested
The purpose of the study is to evaluate the blood pressure lowering effect ...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2008-11
Trial ID
NCT00797316
Treatments Being Tested
This study is designed to compare the blood pressure lowering efficacy of a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT01922141
Treatments Being Tested
Inflammation of the blood vessel plays an important role in the development...
Status
Terminated
Location
VU University Medical Center
Start Date
2011-09
Trial ID
NCT01425242
Treatments Being Tested
The purpose of this study is to assess the effect of Tekturna (aliskiren), ...
Status
Withdrawn
Location
William Beaumont Hospital
Start Date
2009-08
Trial ID
NCT00994253
Treatments Being Tested
Supine hypertension is a common problem that affects at least 50% of patien...
Status
Completed
Location
Vanderbilt University
Start Date
2001-01
Trial ID
NCT00223717
Treatments Being Tested
This study is designed to compare the long-term efficacy and safety of an a...
Status
Completed
Location
Novartis
Start Date
2005-03
Trial ID
NCT00294710
Treatments Being Tested
The goal of this project is to evaluate the chronic effect (8 weeks) of RAS...
Status
Completed
Location
Centre Hospitalier Universitaire Vaudois
Start Date
2011-10
Trial ID
NCT01519635
Treatments Being Tested
To evaluate the blood pressure lowering effect and safety of aliskiren used...
Status
Completed
Location
Investigative Site
Start Date
2005-06
Trial ID
NCT00219102
Treatments Being Tested
The study is designed to primarily assess the effect of aliskiren on albumi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2011-01
Trial ID
NCT01302899